Evolution of transcatheter aortic valve replacement

Circulation Research

Volumn 114, Issue 6, 2014, Pages 1037-1051

  Bourantas, Christos V ^a   Serruys, Patrick W ^a,b  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

aortic valve stenosis; prognosis

Indexed keywords

AORTA VALVE DISEASE; AORTA VALVE REGURGITATION; AORTIC VALVE REPAIR; BALLOON CATHETER; BRAIN CIRCULATION; EMBOLIC PROTECTION DEVICE; FOLLOW UP; GRAFT DYSFUNCTION; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART MUSCLE CONDUCTION DISTURBANCE; HEART VALVE; HUMAN; INVASIVE PROCEDURE; NONHUMAN; PATIENT ASSESSMENT; PERIPHERAL CIRCULATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK ASSESSMENT; TRANSCATHETER AORTIC VALVE IMPLANTATION;

AORTIC VALVE STENOSIS; PROGNOSIS;

AORTIC VALVE; ARRHYTHMIAS, CARDIAC; CARDIAC CATHETERIZATION; CLINICAL TRIALS AS TOPIC; ENDOVASCULAR PROCEDURES; EQUIPMENT DESIGN; EQUIPMENT FAILURE; HEART DISEASES; HEART VALVE PROSTHESIS; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; MULTICENTER STUDIES AS TOPIC; PACEMAKER, ARTIFICIAL; PATIENT SELECTION; PLATELET AGGREGATION INHIBITORS; POSTOPERATIVE COMPLICATIONS; PREMEDICATION; PROGNOSIS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; STROKE; SURGICAL PROCEDURES, MINIMALLY INVASIVE;

EID: 84897849209     PISSN: 00097330     EISSN: 15244571     Source Type: Journal    
DOI: 10.1161/CIRCRESAHA.114.302292     Document Type: Review

References (148)

1. Otto CM, Lind BK, Kitzman DW, Gersh BJ, Siscovick DS. Association of aortic-valve sclerosis with cardiovascular mortality and morbidity in the elderly. N Engl J Med. 1999;341:142-147.
2. Kvidal P, Bergström R, Hörte LG, Ståhle E. Observed and relative survival after aortic valve replacement. J Am Coll Cardiol. 2000;35:747-756.
3. Iung B, Cachier A, Baron G, Messika-Zeitoun D, Delahaye F, Tornos P, Gohlke-Bärwolf C, Boersma E, Ravaud P, Vahanian A. Decision-making in elderly patients with severe aortic stenosis: why are so many denied surgery? Eur Heart J. 2005;26:2714-2720.
4. Cribier A, Eltchaninoff H, Bash A, Borenstein N, Tron C, Bauer F, Derumeaux G, Anselme F, Laborde F, Leon MB. Percutaneous transcath-eter implantation of an aortic valve prosthesis for calcifc aortic stenosis: frst human case description. Circulation. 2002;106:3006-3008.
5. Leon MB, Smith CR, Mack M, et al; PARTNER Trial Investigators. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med. 2010;363:1597-1607.
6. Smith CR, Leon MB, Mack MJ, et al; PARTNER Trial Investigators. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med. 2011;364:2187-2198.
7. Davies H. Catheter-mounted valve for temporary relief of aortic insuf-fciency. Lancet. 1965;1:250.
8. Moulopoulos SD, Anthopoulos L, Stamatelopoulos S, Stefadouros M. Catheter-mounted aortic valves. Ann Thorac Surg. 1971;11:423-430.
9. Phillips SJ, Ciborski M, Freed PS, Cascade PN, Jaron D. A temporary catheter-tip aortic valve: hemodynamic effects on experimental acute aortic insuffciency. Ann Thorac Surg. 1976;21:134-137.
10. Matsubara T, Yamazoe M, Tamura Y, Ohshima M, Yamazaki Y, Suzuki M, Izumi T, Shibata A. Balloon catheter with check valves for experimental relief of acute aortic regurgitation. Am Heart J. 1992;124:1002-1008.
11. Cribier A, Savin T, Saoudi N, Rocha P, Berland J, Letac B. Percutaneous transluminal valvuloplasty of acquired aortic stenosis in elderly patients: an alternative to valve replacement? Lancet. 1986. Jan 11 (8472);1:63-67.
12. McKay RG. The Mansfeld Scientifc Aortic Valvuloplasty Registry: overview of acute hemodynamic results and procedural complications. J Am Coll Cardiol. 1991;17:485-491.
13. Bashore TM, Davidson CJ. Follow-up recatheterization after balloon aortic valvuloplasty. Mansfeld Scientifc Aortic Valvuloplasty Registry Investigators. J Am Coll Cardiol. 1991;17:1188-1195.
14. Andersen HR, Knudsen LL, Hasenkam JM. Transluminal implantation of artifcial heart valves. Description of a new expandable aortic valve and initial results with implantation by catheter technique in closed chest pigs. Eur Heart J. 1992;13:704-708.
15. Bonhoeffer P, Boudjemline Y, Saliba Z, Merckx J, Aggoun Y, Bonnet D, Acar P, Le Bidois J, Sidi D, Kachaner J. Percutaneous replacement of pulmonary valve in a right-ventricle to pulmonary-artery prosthetic conduit with valve dysfunction. Lancet. 2000;356:1403-1405.
16. Cribier A, Eltchaninoff H, Borenstein N, et al. Trans-catheter implantation of balloon-expandable prosthetic heart valves: early results in an animal model. Circulation. 2001;104:II552. Abstract.
17. Paniagua D, Induni E, Ortiz C, Mejia C, Lopez-Jimenez F, Fish RD. Images in cardiovascular medicine. Percutaneous heart valve in the chronic in vitro testing model. Circulation. 2002;106:e51-e52.
18. Paniagua D, Condado JA, Besso J, Vélez M, Burger B, Bibbo S, Cedeno D, Acquatella H, Mejia C, Induni E, Fish RD. First human case of retrograde transcatheter implantation of an aortic valve prosthesis. Tex Heart Inst J. 2005;32:393-398.
19. Cribier A, Eltchaninoff H, Tron C, Bauer F, Agatiello C, Nercolini D, Tapiero S, Litzler PY, Bessou JP, Babaliaros V. Treatment of calcifc aortic stenosis with the percutaneous heart valve: mid-term follow-up from the initial feasibility studies: the French experience. J Am Coll Cardiol. 2006;47:1214-1223.
20. Cribier A, Eltchaninoff H, Tron C, Bauer F, Agatiello C, Sebagh L, Bash A, Nusimovici D, Litzler PY, Bessou JP, Leon MB. Early experience with percutaneous transcatheter implantation of heart valve prosthesis for the treatment of end-stage inoperable patients with calcifc aortic stenosis. J Am Coll Cardiol. 2004;43:698-703.
21. Webb JG, Chandavimol M, Thompson CR, Ricci DR, Carere RG, Munt BI, Buller CE, Pasupati S, Lichtenstein S. Percutaneous aortic valve implantation retrograde from the femoral artery. Circulation. 2006;113:842-850.
22. Walther T, Falk V, Kempfert J, Borger MA, Fassl J, Chu MW, Schuler G, Mohr FW. Transapical minimally invasive aortic valve implantation; the initial 50 patients. Eur J Cardiothorac Surg. 2008;33:983-988.
23. Webb JG, Pasupati S, Humphries K, Thompson C, Altwegg L, Moss R, Sinhal A, Carere RG, Munt B, Ricci D, Ye J, Cheung A, Lichtenstein SV. Percutaneous transarterial aortic valve replacement in selected high-risk patients with aortic stenosis. Circulation. 2007;116:755-763.
24. Piazza N, Grube E, Gerckens U, den Heijer P, Linke A, Luha O, Ramondo A, Ussia G, Wenaweser P, Windecker S, Laborde JC, de Jaegere P, Serruys PW. Procedural and 30-day outcomes following transcatheter aortic valve implantation using the third generation (18 Fr) corevalve revalving system: results from the multicentre, expanded evaluation registry 1-year following CE mark approval. EuroIntervention. 2008;4:242-249.
25. Rodés-Cabau J, Webb JG, Cheung A, et al. Transcatheter aortic valve implantation for the treatment of severe symptomatic aortic stenosis in patients at very high or prohibitive surgical risk: acute and late outcomes of the multicenter Canadian experience. J Am Coll Cardiol. 2010;55:1080-1090.
26. Thomas M, Schymik G, Walther T, Himbert D, Lefèvre T, Treede H, Eggebrecht H, Rubino P, Michev I, Lange R, Anderson WN, Wendler O. Thirty-day results of the SAPIEN aortic Bioprosthesis European Outcome (SOURCE) Registry: A European registry of transcatheter aortic valve implantation using the Edwards SAPIEN valve. Circulation. 2010;122:62-69.
27. Eltchaninoff H, Prat A, Gilard M, Leguerrier A, Blanchard D, Fournial G, Iung B, Donzeau-Gouge P, Tribouilloy C, Debrux JL, Pavie A, Gueret P; FRANCE Registry Investigators. Transcatheter aortic valve implantation: early results of the FRANCE (FRench Aortic National CoreValve and Edwards) registry. Eur Heart J. 2011;32:191-197.
28. Zahn R, Gerckens U, Grube E, Linke A, Sievert H, Eggebrecht H, Hambrecht R, Sack S, Hauptmann KE, Richardt G, Figulla HR, Senges J; German Transcatheter Aortic Valve Interventions-Registry Investigators. Transcatheter aortic valve implantation: frst results from a multi-centre real-world registry. Eur Heart J. 2011;32:198-204.
29. Moat NE, Ludman P, de Belder MA, et al. Long-term outcomes after transcatheter aortic valve implantation in high-risk patients with severe aortic stenosis: the U.K. TAVI (United Kingdom Transcatheter Aortic Valve Implantation) Registry. J Am Coll Cardiol. 2011;58:2130-2138.
30. Linke A, Gerckens U, Wenaweser P, Tamburino C, Bosmans J, Breckerand S, Bauernschmitt R. Treatment of high risk aortic stenosis patients with transcatheter medtronic corevalve implantation: results form the international multi-center advance study. J Am Coll Cardiol. 2012;59:8XXX.
31. Gilard M, Eltchaninoff H, Iung B, et al; FRANCE 2 Investigators. Registry of transcatheter aortic-valve implantation in high-risk patients. N Engl J Med. 2012;366:1705-1715.
32. Onorati F, D'Errigo P, Barbanti M, Rosato S, Covello RD, Maraschini A, Ranucci M, Santoro G, Tamburino C, Grossi C, Santini F, Menicanti L, Seccareccia F. Different impact of sex on baseline characteristics and major periprocedural outcomes of transcatheter and surgical aortic valve interventions: Results of the multicenter Italian OBSERVANT Registry [published online ahead of print July 13, 2013]. J Thorac Cardiovasc Surg. doi: 10.1016/j.jtcvs.2013.05.039.
33. Popma JJ. CoreValve US pivotal trial extreme risk iliofemoral study results. Paper presented at: Transcatheter Cardiovascular Therapeutics; October 28-November 1, 2013; San Francisco, CA.
34. Nielsen HH, Klaaborg KE, Nissen H, Terp K, Mortensen PE, Kjeldsen BJ, Jakobsen CJ, Andersen HR, Egeblad H, Krusell LR, Thuesen L, Hjortdal VE. A prospective, randomised trial of transapical transcatheter aortic valve implantation vs. surgical aortic valve replacement in operable elderly patients with aortic stenosis: the STACCATO trial. EuroIntervention. 2012;8:383-389.
35. Vahanian A, Alferi O, Andreotti F, et al; Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). [Guidelines on the management of valvular heart disease (version 2012). The Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)]. G Ital Cardiol (Rome). 2013;14:167-214.
36. Kahlert P, Knipp SC, Schlamann M, Thielmann M, Al-Rashid F, Weber M, Johansson U, Wendt D, Jakob HG, Forsting M, Sack S, Erbel R, Eggebrecht H. Silent and apparent cerebral ischemia after percutaneous transfemoral aortic valve implantation: a diffusion-weighted magnetic resonance imaging study. Circulation. 2010;121:870-878.
37. Ghanem A, Müller A, Nähle CP, Kocurek J, Werner N, Hammerstingl C, Schild HH, Schwab JO, Mellert F, Fimmers R, Nickenig G, Thomas D. Risk and fate of cerebral embolism after transfemoral aortic valve implantation: a prospective pilot study with diffusion-weighted magnetic resonance imaging. J Am Coll Cardiol. 2010;55:1427-1432.
38. Van Mieghem NM, Schipper ME, Ladich E, Faqiri E, van der Boon R, Randjgari A, Schultz C, Moelker A, van Geuns RJ, Otsuka F, Serruys PW, Virmani R, de Jaegere PP. Histopathology of embolic debris captured during transcatheter aortic valve replacement. Circulation. 2013;127:2194-2201.
39. Thomas M, Schymik G, Walther T, Himbert D, Lefèvre T, Treede H, Eggebrecht H, Rubino P, Colombo A, Lange R, Schwarz RR, Wendler O. One-year outcomes of cohort 1 in the Edwards SAPIEN Aortic Bioprosthesis European Outcome (SOURCE) registry: the European registry of transcatheter aortic valve implantation using the Edwards SAPIEN valve. Circulation. 2011;124:425-433.
40. Bosmans JM, Kefer J, De Bruyne B, Herijgers P, Dubois C, Legrand V, Verheye S, Rodrigus I; Belgian TAVI Registry Participants. Procedural, 30-day and one year outcome following CoreValve or Edwards trans-catheter aortic valve implantation: results of the Belgian national registry. Interact Cardiovasc Thorac Surg. 2011;12:762-767.
41. Miller DC, Blackstone EH, Mack MJ, Svensson LG, Kodali SK, Kapadia S, Rajeswaran J, Anderson WN, Moses JW, Tuzcu EM, Webb JG, Leon MB, Smith CR; PARTNER Trial Investigators and Patients; PARTNER Stroke Substudy Writing Group and Executive Committee. Transcatheter (TAVR) versus surgical (AVR) aortic valve replacement: occurrence, hazard, risk factors, and consequences of neurologic events in the PARTNER trial. J Thorac Cardiovasc Surg. 2012;143:832-843.e13.
42. Stortecky S, Windecker S, Pilgrim T, Heg D, Buellesfeld L, Khattab AA, Huber C, Gloekler S, Nietlispach F, Mattle H, Jüni P, Wenaweser P. Cerebrovascular accidents complicating transcatheter aortic valve implantation: frequency, timing and impact on outcomes. EuroIntervention. 2012;8:62-70.
43. Tay EL, Gurvitch R, Wijesinghe N, Nietlispach F, Nielispach F, Wood D, Cheung A, Ye J, Lichtenstein SV, Carere R, Thompson C, Webb JG. A high-risk period for cerebrovascular events exists after transcatheter aortic valve implantation. JACC Cardiovasc Interv. 2011;4:1290-1297.
44. Rodés-Cabau J, Dauerman HL, Cohen MG, Mehran R, Small EM, Smyth SS, Costa MA, Mega JL, O'Donoghue ML, Ohman EM, Becker RC. Antithrombotic treatment in transcatheter aortic valve implantation: insights for cerebrovascular and bleeding events. J Am Coll Cardiol. 2013;62:2349-2359.
45. Nombela-Franco L, Webb JG, de Jaegere PP, et al. Timing, predictive factors, and prognostic value of cerebrovascular events in a large cohort of patients undergoing transcatheter aortic valve implantation. Circulation. 2012;126:3041-3053.
46. Amat-Santos IJ, Rodés-Cabau J, Urena M, DeLarochellière R, Doyle D, Bagur R, Villeneuve J, Côté M, Nombela-Franco L, Philippon F, Pibarot P, Dumont E. Incidence, predictive factors, and prognostic value of new-onset atrial fbrillation following transcatheter aortic valve implantation. J Am Coll Cardiol. 2012;59:178-188.
47. Walther T, Arsalan M, Kim W, Kempfert J. TAVI: transapical-what else? EuroIntervention. 2013;9(suppl):S19-S24.
48. Naber CK, Ghanem A, Abizaid AA, Wolf A, Sinning JM, Werner N, Nickenig G, Schmitz T, Grube E. First-in-man use of a novel embolic protection device for patients undergoing transcatheter aortic valve implantation. EuroIntervention. 2012;8:43-50.
49. Nietlispach F, Wijesinghe N, Gurvitch R, Tay E, Carpenter JP, Burns C, Wood DA, Webb JG. An embolic defection device for aortic valve interventions. JACC Cardiovasc Interv. 2010;3:1133-1138.
50. Onsea K, Agostoni P, Samim M, Voskuil M, Kluin J, Budde R, Hendrikse J, Ramjankhan F, van Klarenbosch J, Doesburg P, Sieswerda G, Stella P. First-in-man experience with a new embolic defection device in transcath-eter aortic valve interventions. EuroIntervention. 2012;8:51-56.
51. TM embolic defection device in patients undergoing TAVI. Paper presented at: EuroPCR; May 2013; Paris, France.
52. Rodes-Cabau J. Procedural and early neurological outcomes in the PROTAVI-C pilot study. Paper presented at: EuroPCR; May 2013; Paris, France.
53. Holmes DR Jr, Mack MJ, Kaul S, et al. 2012 ACCF/AATS/SCAI/STS expert consensus document on transcatheter aortic valve replacement. J Am Coll Cardiol. 2012;59:1200-1254.
54. Noble S, Asgar A, Cartier R, Virmani R, Bonan R. Anatomo-pathological analysis after CoreValve Revalving system implantation. EuroIntervention. 2009;5:78-85.
55. Ussia GP, Scarabelli M, Mulè M, Barbanti M, Sarkar K, Cammalleri V, Immè S, Aruta P, Pistritto AM, Gulino S, Deste W, Capodanno D, Tamburino C. Dual antiplatelet therapy versus aspirin alone in patients undergoing trans-catheter aortic valve implantation. Am J Cardiol. 2011;108:1772-1776.
56. Mussardo M, Latib A, Chieffo A, et al. Periprocedural and short-term outcomes of transfemoral transcatheter aortic valve implantation with the Sapien XT as compared with the Edwards Sapien valve. JACC Cardiovasc Interv. 2011;4:743-750.
57. Van Mieghem NM, Tchetche D, Chieffo A, et al. Incidence, predictors, and implications of access site complications with transfemoral transcath-eter aortic valve implantation. Am J Cardiol. 2012;110:1361-1367.
58. Lichtenstein SV, Cheung A, Ye J, Thompson CR, Carere RG, Pasupati S, Webb JG. Transapical transcatheter aortic valve implantation in humans: initial clinical experience. Circulation. 2006;114:591-596.
59. Latsios G, Gerckens U, Grube E. Transaortic transcatheter aortic valve implantation: a novel approach for the truly "no-access option" patients. Catheter Cardiovasc Interv. 2010;75:1129-1136.
60. Petronio AS, De Carlo M, Bedogni F, Marzocchi A, Klugmann S, Maisano F, Ramondo A, Ussia GP, Ettori F, Poli A, Brambilla N, Saia F, De Marco F, Colombo A. Safety and effcacy of the subclavian approach for trans-catheter aortic valve implantation with the CoreValve revalving system. Circ Cardiovasc Interv. 2010;3:359-366.
61. De Robertis F, Asgar A, Davies S, Delahunty N, Kelleher A, Trimlett R, Mullen M, Moat N. The left axillary artery-a new approach for transcathe-ter aortic valve implantation. Eur J Cardiothorac Surg. 2009;36:807-812.
62. Modine T, Sudre A, Delhaye C, Fayad G, Lemesle G, Collet F, Koussa M. Transcutaneous aortic valve implantation using the left carotid access: feasibility and early clinical outcomes. Ann Thorac Surg. 2012;93:1489-1494.
63. Dimitriadis Z, Scholtz W, Faber L, Börgermann J, Kleikamp G, Horstkotte D, Wiemer M. Balloon expandable sheath for transfemoral aortic valve implantation: a viable option for patients with challenging access. J Interv Cardiol. 2013;26:84-89.
64. Piva T, Nicolini E, Gabrielli G, Mucaj A, Serenelli M, Rescigno G, Pangrazi A, Perna G. Balloon-expandable sheath for borderline vascular access in transfemoral TAVI. EuroIntervention. 2012;8:Q125.
65. Genereux P, Kodali S, Leon MB, Smith CR, Ben-Gal Y, Kirtane AJ, Daneault B, Reiss GR, Moses JW, Williams MR. Clinical outcomes using a new crossover balloon occlusion technique for percutaneous closure after transfemoral aortic valve implantation. JACC Cardiovasc Interv. 2011;4:861-867.
66. Kahlert P, Al-Rashid F, Plicht B, Konorza T, Neumann T, Thielmann M, Wendt D, Erbel R, Eggebrecht H. Suture-mediated arterial access site closure after transfemoral aortic valve implantation. Catheter Cardiovasc Interv. 2013;81:E139-E150.
67. Blumenstein J, Van Linden A, Arsalan M, Voss S, Moellmann H, Liebetrau C, Thourani VH, Walther T, Kempfert J. Experimental evaluation of a new apical access and closure device. Ann Thorac Surg. 2012;94:1706-1709.
68. Nuis RJ, Van Mieghem NM, Schultz CJ, Tzikas A, Van der Boon RM, Maugenest AM, Cheng J, Piazza N, van Domburg RT, Serruys PW, de Jaegere PP. Timing and potential mechanisms of new conduction abnormalities during the implantation of the Medtronic CoreValve System in patients with aortic stenosis. Eur Heart J. 2011;32:2067-2074.
69. Godin M, Eltchaninoff H, Furuta A, Tron C, Anselme F, Bejar K, Sanchez-Giron C, Bauer F, Litzler PY, Bessou JP, Cribier A. Frequency of conduction disturbances after transcatheter implantation of an Edwards Sapien aortic valve prosthesis. Am J Cardiol. 2010;106:707-712.
70. Cao C, Ang SC, Indraratna P, Manganas C, Bannon P, Black D, Tian D, Yan TD. Systematic review and meta-analysis of transcatheter aortic valve implantation versus surgical aortic valve replacement for severe aortic stenosis. Ann Cardiothorac Surg. 2013;2:10-23.
71. Bagur R, Rodés-Cabau J, Gurvitch R, et al. Need for permanent pacemaker as a complication of transcatheter aortic valve implantation and surgical aortic valve replacement in elderly patients with severe aortic stenosis and similar baseline electrocardiographic fndings. JACC Cardiovasc Interv. 2012;5:540-551.
72. Piazza N, Onuma Y, Jesserun E, Kint PP, Maugenest AM, Anderson RH, de Jaegere PP, Serruys PW. Early and persistent intraventricular conduction abnormalities and requirements for pacemaking after percutaneous replacement of the aortic valve. JACC Cardiovasc Interv. 2008;1:310-316.
73. Moreno R, Dobarro D, López de Sá E, Prieto M, Morales C, Calvo Orbe L, Moreno-Gomez I, Filgueiras D, Sanchez-Recalde A, Galeote G, Jiménez-Valero S, Lopez-Sendon JL. Cause of complete atrioventricular block after percutaneous aortic valve implantation: insights from a necropsy study. Circulation. 2009;120:e29-e30.
74. Ledwoch J, Franke J, Gerckens U, Kuck KH, Linke A, Nickenig G, Krülls-Münch J, Vöhringer M, Hambrecht R, Erbel R, Richardt G, Horack M, Zahn R, Senges J, Sievert H; German Transcatheter Aortic Valve Interventions Registry Investigators. Incidence and predictors of permanent pacemaker implantation following transcatheter aortic valve implantation: analysis from the German transcatheter aortic valve interventions registry. Catheter Cardiovasc Interv. 2013;82:E569-E577.
75. Franzoni I, Latib A, Maisano F, et al. Comparison of incidence and predictors of left bundle branch block after transcatheter aortic valve implantation using the CoreValve versus the Edwards valve. Am J Cardiol. 2013;112:554-559.
76. Schroeter T, Linke A, Haensig M, Merk DR, Borger MA, Mohr FW, Schuler G. Predictors of permanent pacemaker implantation after Medtronic CoreValve bioprosthesis implantation. Europace. 2012;14:1759-1763.
77. Calvi V, Conti S, Pruiti GP, Capodanno D, Puzzangara E, Tempio D, Di Grazia A, Ussia GP, Tamburino C. Incidence rate and predictors of permanent pacemaker implantation after transcatheter aortic valve implantation with self-expanding CoreValve prosthesis. J Interv Card Electrophysiol. 2012;34:189-195.
78. Saia F, Lemos PA, Bordoni B, Cervi E, Boriani G, Ciuca C, Taglieri N, Mariani J Jr, Filho RK, Marzocchi A. Transcatheter aortic valve implantation with a self-expanding nitinol bioprosthesis: prediction of the need for permanent pacemaker using simple baseline and procedural characteristics. Catheter Cardiovasc Interv. 2012;79:712-719.
79. Fraccaro C, Buja G, Tarantini G, Gasparetto V, Leoni L, Razzolini R, Corrado D, Bonato R, Basso C, Thiene G, Gerosa G, Isabella G, Iliceto S, Napodano M. Incidence, predictors, and outcome of conduction disorders after transcatheter self-expandable aortic valve implantation. Am J Cardiol. 2011;107:747-754.
80. Bleiziffer S, Ruge H, Hörer J, Hutter A, Geisbüsch S, Brockmann G, Mazzitelli D, Bauernschmitt R, Lange R. Predictors for new-onset complete heart block after transcatheter aortic valve implantation. JACC Cardiovasc Interv. 2010;3:524-530.
81. Buellesfeld L, Stortecky S, Heg D, et al. Impact of permanent pacemaker implantation on clinical outcome among patients undergoing transcatheter aortic valve implantation. J Am Coll Cardiol. 2012;60:493-501.
82. Urena M, Mok M, Serra V, et al. Predictive factors and long-term clinical consequences of persistent left bundle branch block following transcath-eter aortic valve implantation with a balloon-expandable valve. J Am Coll Cardiol. 2012;60:1743-1752.
83. Houthuizen P, Van Garsse LA, Poels TT, et al. Left bundle-branch block induced by transcatheter aortic valve implantation increases risk of death. Circulation. 2012;126:720-728.
84. Testa L, Latib A, De Marco F, et al. Clinical impact of persistent left bundle-branch block after transcatheter aortic valve implantation with CoreValve Revalving System. Circulation. 2013;127:1300-1307.
85. Hoffmann R, Herpertz R, Lotfpour S, Aktug Ö, Brehmer K, Lehmacher W, Autschbach R, Marx N, Lotf S. Impact of a new conduction defect after transcatheter aortic valve implantation on left ventricular function. JACC Cardiovasc Interv. 2012;5:1257-1263.
86. Tzikas A, van Dalen BM, Van Mieghem NM, Gutierrez-Chico JL, Nuis RJ, Kauer F, Schultz C, Serruys PW, de Jaegere PP, Geleijnse ML. Frequency of conduction abnormalities after transcatheter aortic valve implantation with the Medtronic-CoreValve and the effect on left ventricular ejection fraction. Am J Cardiol. 2011;107:285-289.
87. Willson AB, Rodès-Cabau J, Wood DA, et al. Transcatheter aortic valve replacement with the St. Jude Medical Portico valve: frst-in-human experience. J Am Coll Cardiol. 2012;60:581-586.
88. Treede H, Mohr FW, Baldus S, Rastan A, Ensminger S, Arnold M, Kempfert J, Figulla HR. Transapical transcatheter aortic valve implantation using the JenaValve™ system: acute and 30-day results of the multi-centre CE-mark study. Eur J Cardiothorac Surg. 2012;41:e131-e138.
89. Gooley R, Antonis P, Meredith IT. The next era of transcatheter aortic valve replacement: a case illustrating the beneft of a fully re-positionable, re-sheathable and retrievable prosthesis [published online ahead of print August 31, 2013]. Catheter Cardiovasc Interv. doi: 10.1002/ccd.25182.
90. Sündermann SH, Grünenfelder J, Corti R, Rastan AJ, Linke A, Lange R, Falk V, Bleiziffer S. Feasibility of the Engager™ aortic transcatheter valve system using a fexible over-the-wire design. Eur J Cardiothorac Surg. 2012;42:e48-e52.
91. Schofer J, Colombo A, Klugmann S, et al. Prospective multicenter evaluation of the direct fow medical® transcatheter aortic valve [published online ahead of print October 22, 2013]. J Am Coll Cardiol. 2014;63:763-768.
92. Kempfert J, Treede H, Rastan AJ, Schönburg M, Thielmann M, Sorg S, Mohr FW, Walther T. Transapical aortic valve implantation using a new self-expandable bioprosthesis (ACURATE TA™): 6-month outcomes. Eur J Cardiothorac Surg. 2013;43:52-56; discussion 57.
93. Athappan G, Patvardhan E, Tuzcu EM, Svensson LG, Lemos PA, Fraccaro C, Tarantini G, Sinning JM, Nickenig G, Capodanno D, Tamburino C, Latib A, Colombo A, Kapadia SR. Incidence, predictors, and outcomes of aortic regurgitation after transcatheter aortic valve replacement: meta-analysis and systematic review of literature. J Am Coll Cardiol. 2013;61:1585-1595.
94. Kodali SK, Williams MR, Smith CR, et al; PARTNER Trial Investigators. Two-year outcomes after transcatheter or surgical aortic-valve replacement. N Engl J Med. 2012;366:1686-1695.
95. Tamburino C, Capodanno D, Ramondo A, et al. Incidence and predictors of early and late mortality after transcatheter aortic valve implantation in 663 patients with severe aortic stenosis. Circulation. 2011;123:299-308.
96. Willson AB, Webb JG, Labounty TM, et al. 3-dimensional aortic annular assessment by multidetector computed tomography predicts moderate or severe paravalvular regurgitation after transcatheter aortic valve replacement: a multicenter retrospective analysis. J Am Coll Cardiol. 2012;59:1287-1294.
97. Bloomfeld GS, Gillam LD, Hahn RT, Kapadia S, Leipsic J, Lerakis S, Tuzcu M, Douglas PS. A practical guide to multimodality imaging of transcatheter aortic valve replacement. JACC Cardiovasc Imaging. 2012;5:441-455.
98. Jilaihawi H, Kashif M, Fontana G, Furugen A, Shiota T, Friede G, Makhija R, Doctor N, Leon MB, Makkar RR. Cross-sectional computed tomographic assessment improves accuracy of aortic annular sizing for transcatheter aortic valve replacement and reduces the incidence of paravalvular aortic regurgitation. J Am Coll Cardiol. 2012;59:1275-1286.
99. Jabbour A, Ismail TF, Moat N, Gulati A, Roussin I, Alpendurada F, Park B, Okoroafor F, Asgar A, Barker S, Davies S, Prasad SK, Rubens M, Mohiaddin RH. Multimodality imaging in transcatheter aortic valve implantation and post-procedural aortic regurgitation: comparison among cardiovascular magnetic resonance, cardiac computed tomography, and echocardiography. J Am Coll Cardiol. 2011;58:2165-2173.
100. Schultz C, Rossi A, Van Mieghem N, van der Boon R, Papadopoulou SL, van Domburg R, Moelker A, Mollet N, Krestin G, van Geuns RJ, Nieman K, de Feyter P, Serruys PW, de Jaegere P. Aortic annulus dimensions and leafet calcifcation from contrast MSCT predict the need for balloon post-dilatation after TAVI with the Medtronic CoreValve prosthesis. EuroIntervention. 2011;7:564-572.
101. Tzikas A, Schultz C, Van Mieghem NM, de Jaegere PP, Serruys PW. Optimal projection estimation for transcatheter aortic valve implantation based on contrast-aortography: validation of a Prototype Software. Catheter Cardiovasc Interv. 2010;76:602-607.
102. de Vaan J, Verstraeten L, de Jaegere P, Schultz C. The 3mensio Valves™ multimodality workstation. EuroIntervention. 2012;7:1464-1469.
103. Kempfert J, Noettling A, John M, Rastan A, Mohr FW, Walther T. Automatically segmented DynaCT: enhanced imaging during transcath-eter aortic valve implantation. J Am Coll Cardiol. 2011;58:e211.
104. Bourantas CV, Van Mieghem NM, Farooq V, Soliman OI, Windecker S, Piazza N, Serruys PW. Future perspectives in transcatheter aortic valve implantation. Int J Cardiol. 2013;168:11-18.
105. Watanabe Y, Morice MC, Bouvier E, Leong T, Hayashida K, Lefèvre T, Hovasse T, Romano M, Chevalier B, Donzeau-Gouge P, Farge A, Cormier B, Garot P. Automated 3-dimensional aortic annular assessment by multidetector computed tomography in transcatheter aortic valve implantation. JACC Cardiovasc Interv. 2013;6:955-964.
106. Blumenstein JM, Van Linden A, Moellmann H, Seeburger J, Rastan A, Kim WK, Mohr FW, Kempfert J, Walther T. DynaCT-guided anatomical rotation of the SAPIEN XT valve during transapical aortic valve implantation: proof of concept. Thorac Cardiovasc Surg. 2013;61:409-413.
107. Poon KK, Crowhurst J, James C, Campbell D, Roper D, Chan J, Incani A, Clarke A, Tesar P, Aroney C, Raffel OC, Walters DL. Impact of optimising fuoroscopic implant angles on paravalvular regurgitation in transcatheter aortic valve replacements-utility of three-dimensional rotational angiography. EuroIntervention. 2012;8:538-545.
108. Ribeiro HB, Nombela-Franco L, Urena M, Mok M, Pasian S, Doyle D, DeLarochellière R, Côté M, Lafamme L, DeLarochellière H, Allende R, Dumont E, Rodés-Cabau J. Coronary obstruction following transcath-eter aortic valve implantation: a systematic review. JACC Cardiovasc Interv. 2013;6:452-461.
109. Ribeiro HB, Webb JG, Makkar RR, et al. Predictive factors, management, and clinical outcomes of coronary obstruction following transcath-eter aortic valve implantation: insights from a large multicenter registry. J Am Coll Cardiol. 2013;62:1552-1562.
110. Rodés-Cabau J, Gutiérrez M, Bagur R, De Larochellière R, Doyle D, Côté M, Villeneuve J, Bertrand OF, Larose E, Manazzoni J, Pibarot P, Dumont E. Incidence, predictive factors, and prognostic value of myo-cardial injury following uncomplicated transcatheter aortic valve implantation. J Am Coll Cardiol. 2011;57:1988-1999.
111. Yong ZY, Wiegerinck EM, Boerlage-van Dijk K, Koch KT, Vis MM, Bouma BJ, Henriques JP, Cocchieri R, Piek JJ, de Mol BA, Baan J Jr. Predictors and prognostic value of myocardial injury during transcatheter aortic valve implantation. Circ Cardiovasc Interv. 2012;5:415-423.
112. Carrabba N, Valenti R, Migliorini A, Vergara R, Parodi G, Antoniucci D. Prognostic value of myocardial injury following transcatheter aortic valve implantation. Am J Cardiol. 2013;111:1475-1481.
113. Roy DA, Laborde JC, Sharma R, Jahangiri M, Brecker SJ. First-in-man assessment of a dedicated guidewire for transcatheter aortic valve implantation. EuroIntervention. 2013;8:1019-1025.
114. Hekimian G, Detaint D, Messika-Zeitoun D, Attias D, Iung B, Himbert D, Brochet E, Vahanian A. Mitral regurgitation in patients referred for transcatheter aortic valve implantation using the Edwards Sapien prosthesis: mechanisms and early postprocedural changes. J Am Soc Echocardiogr. 2012;25:160-165.
115. Giordana F, Capriolo M, Frea S, et al. Impact of TAVI on mitral regur-gitation: a prospective echocardiographic study. Echocardiography. 2013;30:250-257.
116. Hutter A, Bleiziffer S, Richter V, Opitz A, Hettich I, Mazzitelli D, Ruge H, Lange R. Transcatheter aortic valve implantation in patients with concomitant mitral and tricuspid regurgitation. Ann Thorac Surg. 2013;95:77-84.
117. D'Onofrio A, Gasparetto V, Napodano M, Bianco R, Tarantini G, Renier V, Isabella G, Gerosa G. Impact of preoperative mitral valve regurgi-tation on outcomes after transcatheter aortic valve implantation. Eur J Cardiothorac Surg. 2012;41:1271-1276; discussion 1276.
118. Al-Attar N, Ghodbane W, Himbert D, Rau C, Raffoul R, Messika-Zeitoun D, Brochet E, Vahanian A, Nataf P. Unexpected complications of trans-apical aortic valve implantation. Ann Thorac Surg. 2009;88:90-94.
119. De Chiara B, Moreo A, De Marco F, Musca F, Oreglia J, Lobiati E, Bruschi G, Belli O, Mauri F, Klugmann S. Infuence of CoreValve ReValving System implantation on mitral valve function: an echo-cardiographic study in selected patients. Catheter Cardiovasc Interv. 2011;78:638-644.
120. Généreux P, Head SJ, Wood DA, Kodali SK, Williams MR, Paradis JM, Spaziano M, Kappetein AP, Webb JG, Cribier A, Leon MB. Transcatheter aortic valve implantation: 10-year anniversary part II: clinical implications. Eur Heart J. 2012;33:2399-2402.
121. Schuler G, Schroeder R, Linke A. Heart leafet technology valve. EuroIntervention. 2013;9 (suppl):S115-S117.
122. Binder RK, Schäfer U, Kuck KH, Wood DA, Moss R, Leipsic J, Toggweiler S, Freeman M, Ostry AJ, Frerker C, Willson AB, Webb JG. Transcatheter aortic valve replacement with a new self-expanding trans-catheter heart valve and motorized delivery system. JACC Cardiovasc Interv. 2013;6:301-307.
123. Binder RK, Rodés-Cabau J, Wood DA, Mok M, Leipsic J, De Larochellière R, Toggweiler S, Dumont E, Freeman M, Willson AB, Webb JG. Transcatheter aortic valve replacement with the SAPIEN 3: a new balloon-expandable transcatheter heart valve. JACC Cardiovasc Interv. 2013;6:293-300.
124. Patel DN, Bailey SR. Nanotechnology in cardiovascular medicine. Catheter Cardiovasc Interv. 2007;69:643-654.
125. Sutherland FW, Perry TE, Yu Y, Sherwood MC, Rabkin E, Masuda Y, Garcia GA, McLellan DL, Engelmayr GC Jr, Sacks MS, Schoen FJ, Mayer JE Jr. From stem cells to viable autologous semilunar heart valve. Circulation. 2005;111:2783-2791.
126. Emmert MY, Weber B, Wolint P, Behr L, Sammut S, Frauenfelder T, Frese L, Scherman J, Brokopp CE, Templin C, Grünenfelder J, Zünd G, Falk V, Hoerstrup S P. Stem cell-based transcatheter aortic valve implantation: frst experiences in a pre-clinical model. JACC Cardiovasc Interv. 2012;5:874-883.
127. Emmert MY, Weber B, Behr L, Sammut S, Frauenfelder T, Wolint P, Scherman J, Bettex D, Grunenfelder J, Falk V, Hoerstrup SP. Transcatheter aortic valve implantation using anatomically oriented, marrow stromal cell-based, stented, tissue-engineered heart valves: technical considerations and implications for translational cell-based heart valve concepts. Eur J Cardiothorac Surg. 2013;45:61-68.
128. Serruys PW. A sense of "déjà vu"? EuroIntervention. 2013;9:535.
129. Rosenhek R, Iung B, Tornos P, Antunes MJ, Prendergast BD, Otto CM, Kappetein AP, Stepinska J, Kaden JJ, Naber CK, Acartürk E, Gohlke-Bärwolf C. ESC Working Group on Valvular Heart Disease Position Paper: assessing the risk of interventions in patients with valvular heart disease. Eur Heart J. 2012;33:822-828, 828a, 828b.
130. Kappetein AP, Head SJ, Généreux P, et al; Valve Academic Research Consortium-2. Updated standardized endpoint defnitions for trans-catheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. EuroIntervention. 2012;8:782-795.
131. Stortecky S, Schoenenberger AW, Moser A, Kalesan B, Jüni P, Carrel T, Bischoff S, Schoenenberger CM, Stuck AE, Windecker S, Wenaweser P. Evaluation of multidimensional geriatric assessment as a predictor of mortality and cardiovascular events after transcatheter aortic valve implantation. JACC Cardiovasc Interv. 2012;5:489-496.
132. Piazza N, Wenaweser P, van Gameren M, et al. Relationship between the logistic EuroSCORE and the Society of Thoracic Surgeons Predicted Risk of Mortality score in patients implanted with the CoreValve ReValving system-a Bern-Rotterdam Study. Am Heart J. 2010;159:323-329.
133. Haensig M, Holzhey DM, Borger MA, Schuler G, Shi W, Subramanian S, Rastan AJ, Mohr FW. Is the new EuroSCORE II a better predictor for transapical aortic valve implantation? Eur J Cardiothorac Surg. 2013;44:302-308; discussion 308.
134. Goetzenich A, Deppe I, Schnöring H, Gafencu GL, Gafencu DA, Yildirim H, Tewarie L, Spillner J, Moza A. EuroScore 2 for identifca-tion of patients for transapical aortic valve replacement-a single center retrospective in 206 patients. J Cardiothorac Surg. 2012;7:89.
135. Stähli BE, Tasnady H, Lüscher TF, Gebhard C, Mikulicic F, Erhart L, Bühler I, Landmesser U, Altwegg L, Wischnewsky MB, Grünenfelder J, Falk V, Corti R, Maier W. Early and late mortality in patients undergoing transcatheter aortic valve implantation: comparison of the novel EuroScore II with established risk scores. Cardiology. 2013;126:15-23.
136. Van Mieghem NM, Head SJ, van der Boon RM, Piazza N, de Jaegere PP, Carrel T, Kappetein AP, Lange R, Walther T, Windecker S, van Es GA, Serruys PW. The SURTAVI model: proposal for a pragmatic risk stratifcation for patients with severe aortic stenosis. EuroIntervention. 2012;8:258-266.
137. Schoenenberger AW, Stortecky S, Neumann S, Moser A, Jüni P, Carrel T, Huber C, Gandon M, Bischoff S, Schoenenberger CM, Stuck AE, Windecker S, Wenaweser P. Predictors of functional decline in elderly patients undergoing transcatheter aortic valve implantation (TAVI). Eur Heart J. 2013;34:684-692.
138. Piazza N, Lange R, Martucci G, Serruys PW. Patient selection for trans-catheter aortic valve implantation: patient risk profle and anatomical selection criteria. Arch Cardiovasc Dis. 2012;105:165-173.
139. Wenaweser P, Stortecky S, Schwander S, Heg D, Huber C, Pilgrim T, Gloekler S, O'Sullivan CJ, Meier B, Jüni P, Carrel T, Windecker S. Clinical outcomes of patients with estimated low or intermediate surgical risk undergoing transcatheter aortic valve implantation. Eur Heart J. 2013;34:1894-1905.
140. Lange R, Bleiziffer S, Mazzitelli D, Elhmidi Y, Opitz A, Krane M, Deutsch MA, Ruge H, Brockmann G, Voss B, Schreiber C, Tassani P, Piazza N. Improvements in transcatheter aortic valve implantation outcomes in lower surgical risk patients: a glimpse into the future. J Am Coll Cardiol. 2012;59:280-287.
141. Piazza N, Kalesan B, Van Mieghem N, Head S, Wenaweser P, Carrel TP, Bleiziffer S, de Jaegere PP, Gahl B, Anderson RH, Kappetein AP, Lange R, Serruys PW, Windecker S, Jüni P. A 3-center comparison of 1-year mortality outcomes between transcatheter aortic valve implantation and surgical aortic valve replacement on the basis of propensity score matching among intermediate-risk surgical patients. JACC Cardiovasc Interv. 2013;6:443-451.
142. Roy DA, Schaefer U, Guetta V, et al. Transcatheter aortic valve implantation for pure severe native aortic valve regurgitation. J Am Coll Cardiol. 2013;61:1577-1584.
143. Seiffert M, Diemert P, Koschyk D, Schirmer J, Conradi L, Schnabel R, Blankenberg S, Reichenspurner H, Baldus S, Treede H. Transapical implantation of a second-generation transcatheter heart valve in patients with noncalcifed aortic regurgitation. JACC Cardiovasc Interv. 2013;6:590-597.
144. Kempfert J, Van Linden A, Linke A, Borger MA, Rastan A, Mukherjee C, Ender J, Schuler G, Mohr FW, Walther T. Transapical off-pump valve-in-valve implantation in patients with degenerated aortic xeno-grafts. Ann Thorac Surg. 2010;89:1934-1941.
145. Dvir D, Webb J, Brecker S, et al. Transcatheter aortic valve replacement for degenerative bioprosthetic surgical valves: results from the global valve-in-valve registry. Circulation. 2012;126:2335-2344.
146. Webb JG, Wood DA, Ye J, et al. Transcatheter valve-in-valve implantation for failed bioprosthetic heart valves. Circulation. 2010;121:1848-1857.
147. Piazza N, Bleiziffer S, Brockmann G, Hendrick R, Deutsch MA, Opitz A, Mazzitelli D, Tassani-Prell P, Schreiber C, Lange R. Transcatheter aortic valve implantation for failing surgical aortic bioprosthetic valve: from concept to clinical application and evaluation (part 2). JACC Cardiovasc Interv. 2011;4:733-742.
148. Eggebrecht H, Schäfer U, Treede H, Boekstegers P, Babin-Ebell J, Ferrari M, Möllmann H, Baumgartner H, Carrel T, Kahlert P, Lange P, Walther T, Erbel R, Mehta RH, Thielmann M. Valve-in-valve transcath-eter aortic valve implantation for degenerated bioprosthetic heart valves. JACC Cardiovasc Interv. 2011;4:1218-1227.